06Jun
Supreme Court Decides Prescription Drug Preemption Case in Favor of Drug Manufacturer
The United States Supreme Court finally clarified its 11-year-old “clear evidence” standard for pharmaceutical preemption. In its much-anticipated opinion delivered by Justice Breyer, the Court unanimously reversed the Third Circuit’s holding that...
By:
Morrison & Foerster LLP - Class Dismissed
Related
FDI restrictions have been on the political agenda in Europe and further afield for at least the pas...
Read More >
If you’re an employer in Maryland, beginning October 1, 2019, you are prohibited from requiring a l...
Read More >
Recently issued proposed regulations clarify changes made by the TCJA to the tax deductibility of ex...
Read More >
It is often taken for granted that only the named parties to a contract can enforce it. The English ...
Read More >
New York Governor Andrew Cuomo recently signed legislation amending state law to explicitly prohibit...
Read More >
Private equity exits of all types have fallen, but secondary buyouts have shown the greatest decline...
Read More >